In this Issue
Could SLT be considered an outflow drug?
By Mark A. Latina, MD, and John Mark S. de Leon, MD
Efforts to detect early glaucoma.
By Christopher A. Girkin, MD
Approaching cases of zonular weakness.
By Iqbal Ike K. Ahmed, MD, and Michael Butler, MD
Focusing on dialogue and education can improve treatment.
By Thomas E. Bournias, MD
Viewpoint No. 1: Considering this factor promotes the more effective treatment of patients.
By Alan L. Robin, MD
By Richard A. Lehrer, MD
By Don Minckler, MD
The history and utility of this technology.
By Robert D. Fechtner, MD
Viewpoint No. 2: This factor is mutable and therefore not important.